IFRA defends QRA
This article was originally published in The Rose Sheet
Executive Summary
Despite advocacy group Cropwatch's call to boycott the International Fragrance Association's 40th amendment to its Code of Practice, which implements a quantitative - versus qualitative - risk assessment method for gauging fragrance allergenicity, the initiative is moving ahead as planned, IFRA members said Feb. 28 during CTFA's annual meeting in Boca Raton, Fla. "Cropwatch was saying basically that the QRA system was too complicated for smaller companies - too expensive and cumbersome," IFRA Director General Jean-Pierre Houri noted. "But we cannot put our head in the sand and refuse what is considered to be by the best scientific minds as a major step forward in the field of dermal sensitization." IFRA maintains that the new system allows perfumers more flexibility in designing fragrances and that it allows the association to "lead, rather than follow," according to Anne Marie Api, Ph.D, VP of Human Health Sciences for RIFM. "We [will] be frontrunners. We [will] be leading and showing that we're taking responsibility for the fragrance allergy issue." Cropwatch announced its boycott in January (1"The Rose Sheet" Jan. 29, 2007, p. 3)...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.